CRYSTALLINE FORM OF (3R,5R)-7-[4-BENZYLCARBAMOYL-2-(4-FLUOROPHENYL)-5-ISOPROPYL-IMIDAZOL-1-YL]-3,5-DIHYDROXYHEPTANOIC ACID SODIUM SALT

PROBLEM TO BE SOLVED: To provide a new crystalline form of (3R,5R)-7-[4-benzylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-imidazol-1-yl]-3,5-dihydroxyheptanoic acid sodium salt. SOLUTION: This new crystalline form A of (3R,5R)-7-[4-benzylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-imidazol-1-yl]-3,5-dihyd...

Full description

Saved in:
Bibliographic Details
Main Author MILLER JONATHAN MARK
Format Patent
LanguageEnglish
Published 17.05.2007
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide a new crystalline form of (3R,5R)-7-[4-benzylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-imidazol-1-yl]-3,5-dihydroxyheptanoic acid sodium salt. SOLUTION: This new crystalline form A of (3R,5R)-7-[4-benzylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-imidazol-1-yl]-3,5-dihydroxyheptanoic acid sodium salt is described. COPYRIGHT: (C)2007,JPO&INPIT
Bibliography:Application Number: JP20060291882